152 related articles for article (PubMed ID: 19617954)
1. Significance of system L amino acid transporter 1 (LAT-1) and 4F2 heavy chain (4F2hc) expression in human developing intestines.
Ohno C; Nakanishi Y; Honma T; Henmi A; Sugitani M; Kanai Y; Nemoto N
Acta Histochem Cytochem; 2009 Jun; 42(3):73-81. PubMed ID: 19617954
[TBL] [Abstract][Full Text] [Related]
2. Expression of amino acid transporter LAT1 and 4F2hc in the healing process after the implantation of a tooth ash and plaster of Paris mixture.
Kim SG; Ahn YC; Yoon JH; Kim HK; Park SS; Ahn SG; Endou H; Kanai Y; Park JC; Kim DK
In Vivo; 2006; 20(5):591-7. PubMed ID: 17091765
[TBL] [Abstract][Full Text] [Related]
3. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
Yan R; Zhao X; Lei J; Zhou Q
Nature; 2019 Apr; 568(7750):127-130. PubMed ID: 30867591
[TBL] [Abstract][Full Text] [Related]
4. Expression of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in liver tumor lesions of rat models.
Ohkame H; Masuda H; Ishii Y; Kanai Y
J Surg Oncol; 2001 Dec; 78(4):265-71; discussion 271-2. PubMed ID: 11745822
[TBL] [Abstract][Full Text] [Related]
5. Expression of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in oral squamous cell carcinoma and its precusor lesions.
Kim DK; Ahn SG; Park JC; Kanai Y; Endou H; Yoon JH
Anticancer Res; 2004; 24(3a):1671-5. PubMed ID: 15274339
[TBL] [Abstract][Full Text] [Related]
6. Essential Roles of L-Type Amino Acid Transporter 1 in Syncytiotrophoblast Development by Presenting Fusogenic 4F2hc.
Ohgaki R; Ohmori T; Hara S; Nakagomi S; Kanai-Azuma M; Kaneda-Nakashima K; Okuda S; Nagamori S; Kanai Y
Mol Cell Biol; 2017 Jun; 37(11):. PubMed ID: 28320871
[TBL] [Abstract][Full Text] [Related]
7. Expression of amino acid transporter (LAT1 and 4F2hc) in pulmonary pleomorphic carcinoma.
Kaira K; Kawashima O; Endoh H; Imaizumi K; Goto Y; Kamiyoshihara M; Sugano M; Yamamoto R; Osaki T; Tanaka S; Fujita A; Imai H; Kogure Y; Seki Y; Shimizu K; Mogi A; Shitara Y; Oyama T; Kanai Y; Asao T
Hum Pathol; 2019 Feb; 84():142-149. PubMed ID: 30300664
[TBL] [Abstract][Full Text] [Related]
8. Correlation of L-methyl-11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas.
Okubo S; Zhen HN; Kawai N; Nishiyama Y; Haba R; Tamiya T
J Neurooncol; 2010 Sep; 99(2):217-25. PubMed ID: 20091333
[TBL] [Abstract][Full Text] [Related]
9. The Heavy Chain 4F2hc Modulates the Substrate Affinity and Specificity of the Light Chains LAT1 and LAT2.
Kantipudi S; Jeckelmann JM; Ucurum Z; Bosshart PD; Fotiadis D
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066406
[TBL] [Abstract][Full Text] [Related]
10. Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
Pineda M; Fernández E; Torrents D; Estévez R; López C; Camps M; Lloberas J; Zorzano A; Palacín M
J Biol Chem; 1999 Jul; 274(28):19738-44. PubMed ID: 10391915
[TBL] [Abstract][Full Text] [Related]
11. Contribution of LAT1-4F2hc in Urological Cancers via Toll-like Receptor and Other Vital Pathways.
Zhao X; Sakamoto S; Maimaiti M; Anzai N; Ichikawa T
Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008399
[TBL] [Abstract][Full Text] [Related]
12. Molecular events involved in up-regulating human Na+-independent neutral amino acid transporter LAT1 during T-cell activation.
Nii T; Segawa H; Taketani Y; Tani Y; Ohkido M; Kishida S; Ito M; Endou H; Kanai Y; Takeda E; Miyamoto Ki
Biochem J; 2001 Sep; 358(Pt 3):693-704. PubMed ID: 11535130
[TBL] [Abstract][Full Text] [Related]
13. Expression of heteromeric amino acid transporters along the murine intestine.
Dave MH; Schulz N; Zecevic M; Wagner CA; Verrey F
J Physiol; 2004 Jul; 558(Pt 2):597-610. PubMed ID: 15155792
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of a membrane protein (y+L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y+L. A candidate gene for lysinuric protein intolerance.
Torrents D; Estévez R; Pineda M; Fernández E; Lloberas J; Shi YB; Zorzano A; Palacín M
J Biol Chem; 1998 Dec; 273(49):32437-45. PubMed ID: 9829974
[TBL] [Abstract][Full Text] [Related]
15. L-type amino acid transporter-1 expressed in human astrocytomas, U343MGa.
Asano S; Kameyama M; Oura A; Morisato A; Sakai H; Tabuchi Y; Chairoungdua A; Endou H; Kanai Y
Biol Pharm Bull; 2007 Mar; 30(3):415-22. PubMed ID: 17329830
[TBL] [Abstract][Full Text] [Related]
16.
Kantipudi S; Harder D; Bonetti S; Fotiadis D; Jeckelmann JM
Methods Protoc; 2021 Jul; 4(3):. PubMed ID: 34449687
[TBL] [Abstract][Full Text] [Related]
17. LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
Rossier G; Meier C; Bauch C; Summa V; Sordat B; Verrey F; Kühn LC
J Biol Chem; 1999 Dec; 274(49):34948-54. PubMed ID: 10574970
[TBL] [Abstract][Full Text] [Related]
18. Expression of LAT1 and 4F2hc in Gastroenteropancreatic Neuroendocrine Neoplasms.
Horita Y; Kaira K; Kawasaki T; Mihara Y; Sakuramoto S; Yamaguchi S; Okamoto K; Ryozawa S; Kanai Y; Yasuda M; Hamaguchi T
In Vivo; 2021; 35(4):2425-2432. PubMed ID: 34182526
[TBL] [Abstract][Full Text] [Related]
19. Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains.
Bröer A; Friedrich B; Wagner CA; Fillon S; Ganapathy V; Lang F; Bröer S
Biochem J; 2001 May; 355(Pt 3):725-31. PubMed ID: 11311135
[TBL] [Abstract][Full Text] [Related]
20. The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier.
Kageyama T; Nakamura M; Matsuo A; Yamasaki Y; Takakura Y; Hashida M; Kanai Y; Naito M; Tsuruo T; Minato N; Shimohama S
Brain Res; 2000 Oct; 879(1-2):115-21. PubMed ID: 11011012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
